Comments
Loading...
Compass Pathways (CMPS) Forecast
NewsEarningsCompass Pathways (CMPS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestCompass Pathways (NASDAQ:CMPS) Stock Quotes, Forecast and News Summary
Compass Pathways Stock (NASDAQ: CMPS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Compass Pathways (CMPS) stock?
You can purchase shares of Compass Pathways (NASDAQ:CMPS) through any online brokerage.
Who are Compass Pathways (CMPS) competitors?
Other companies in Compass Pathways’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
What is the forecast, or price target, for Compass Pathways (CMPS) stock?
Compass Pathways has a consensus price target of $29.60.
What is the current price for Compass Pathways (CMPS)?
The stock price for Compass Pathways (NASDAQ: CMPS) is $4.54 last updated November 21, 2024 at 11:06 AM EST.
Does Compass Pathways (CMPS) pay a dividend?
There are no upcoming dividends for Compass Pathways.
When is Compass Pathways (NASDAQ:CMPS) reporting earnings?
Compass Pathways’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Compass Pathways (CMPS) going to split?
There is no upcoming split for Compass Pathways.
What sector and industry does Compass Pathways (CMPS) operate in?
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.